Physician

Mohammed Amjad Ranginwala, M.D

According to 2025 Medicare claims, Mohammed Ranginwala, M.D (NPI: 1154480994) practices internal medicine in the South Bend-Mishawaka, IN-MI market, with the plurality of this provider's patient population coming from Cass, MI. This provider's primary affiliated billing organization is DR WALA MEDICAL CLINIC PLC (NPI: 1548607039; TIN: 46-2836127) and primary practice location at 49047-1624.

Ranginwala's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 53 traditional Medicare patients, billed 621 HCPCS/CPT codes, and received $33,879 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 3,537 prescription claims across 137 beneficiaries totaling $386,788 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). 2023 DME data shows 24 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $95,646 to $33,879. In contrast, Part D prescription costs have risen steadily, from $253,901 to $386,788. For DME billing, this smaller-volume category started with an early spike, then settled into a lower baseline, moving from $15,597 to $1,662.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	151	1,820	$95,646
2016	111	1,537	$72,501
2017	114	1,477	$71,631
2018	114	1,528	$84,436
2019	109	1,321	$70,109
2020	101	1,151	$62,222
2021	75	1,274	$53,493
2022	72	896	$46,057
2023	55	626	$36,428
2024	53	621	$33,879

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	180	4,315	$253,901
2016	164	4,029	$247,933
2017	152	3,868	$248,045
2018	173	4,173	$288,062
2019	160	4,068	$414,140
2020	171	4,019	$339,782
2021	141	3,343	$319,788
2022	144	3,065	$318,784
2023	124	2,940	$375,095
2024	137	3,537	$386,788

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	34	318	$12,966
2016	14	141	$4,935
2017	N/R	68	$3,757
2018	N/R	35	$641
2019	N/R	61	$1,192
2020	N/R	28	$828
2021	N/R	15	$1,139
2022	N/R	48	$2,054
2023	N/R	24	$1,603
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	34	34	$122
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	51	200	$86
99497	Advance care planning, first 30 minutes	38	39	$73
G0008	Administration of influenza virus vaccine	33	33	$31
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	45	141	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	68	3,120	$63,178
Januvia	Sitagliptin Phosphate	49	3,100	$55,073
Ozempic	Semaglutide	43	1,794	$53,058
Eliquis	Apixaban	32	1,666	$31,612
Jardiance	Empagliflozin	19	1,350	$25,152

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Mohammed Amjad Ranginwala, M.D?

Tedicare shows public-source Medicare data for Mohammed Amjad Ranginwala, M.D (NPI 1154480994), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mohammed Amjad Ranginwala, M.D have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mohammed Amjad Ranginwala, M.D?

Mohammed Amjad Ranginwala, M.D is linked to DR WALA MEDICAL CLINIC PLC (billing NPI 1548607039) in the available physician profile data.

Does Mohammed Amjad Ranginwala, M.D have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.